Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Greifswald
Clinical trial register · Germany

Clinical Trials in Greifswald, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Berlin 1587 Hamburg 893 Essen 765 Dresden 714 Heidelberg 626
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Medicine Greifswald13 Hoffmann-La Roche5 AstraZeneca3 Janssen Research & Development, LLC3 Ipsen3 Genmab2 Novartis Pharmaceuticals2 European Myeloma Network B.V.2 Merz Therapeutics GmbH2 Technische Universität Dresden2 Stichting Hemato-Oncologie voor Volwassenen Nederland2 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2 University of Leipzig2 AbbVie2 AOP Orphan Pharmaceuticals AG2 Assistance Publique - Hôpitaux de Paris1 Universität des Saarlandes1 SECRETO Study Consortium1 Heidelberg University1 Prof. Dr. Dr. Birgit Burkhardt1 Kura Oncology, Inc.1 Pomeranian Medical University Szczecin1 Valentina Puentmann1 RECORDATI GROUP1 GRIN Therapeutics, Inc.1 Show all 47
Site location
Berlin1587 Hamburg893 Essen765 Dresden714 Heidelberg626 Cologne619 Leipzig513 München510 Hanover487 Tübingen454 Bonn422 Düsseldorf409 Munich398 Freiburg im Breisgau394 Erlangen374 Frankfurt369 Münster359 Frankfurt am Main343 Ulm343 Mainz336 Würzburg296 Aachen266 Augsburg248 Kiel234 Lübeck225 Show all 638
All 638 locations
Target enrolment
to

Trials with a site in Greifswald

79 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Hoffmann-La Roche
Phase 2
45
Nuremberg, Greifswald, Heidelberg, Jena, Kiel
2026-11-03
Not yet open
University Hospital, Basel, Switzerland
Phase 2
66
Würzburg, Greifswald, Cologne, Hagen, Hamburg
2026-11
Not yet open
Microbiology Operations & Time Optimization in Sepsis
NCT07817043Sepsis, Bloodstream Infection, Bacterial Infections, Septic Shock
University Medicine Greifswald
Observational
1,000
Greifswald
2026-10-01
Not yet open
University Medicine Greifswald
Not applicable
30
Greifswald
2026-09-21
Recruiting
Efficacy of the Proactive Automatized Lifestyle Intervention
NCT07441603Health Risk Behaviors, Tobacco Smoking, Alcohol Use, Unhealthy Diet, Exercise, Smoking, and Alcohol Use
University Medicine Greifswald
Not applicable
788
Greifswald
2026-06-25
Recruiting
Hoffmann-La Roche
Phase 3
380
Bad Saarow, Berlin, Düsseldorf, Frankfurt, Greifswald, Kiel
2026-06-23
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Halle, Greifswald, Mainz
2026-05-06
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
NCT07285655Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc.
Phase 3
344
Cologne, Essen, Giessen, Greifswald, Hamburg, Hanover, Munich
2026-04-23
Recruiting
A Comparison of Fisetin Kinetics in Young and Old Adults
NCT06796374Pharmacokinetic Study in Healthy Volunteers
University Medicine Greifswald
Not applicable
80
Greifswald
2026-03-31
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Aachen, Bochum, Bonn, Braunschweig, Greifswald, Halle, Hamburg, Hanover
2026-03-01
Recruiting
Bayer
Phase 4
50
Ulm, Darmstadt, Greifswald, Bonn, Berlin, Hamburg
2026-02-13
Recruiting
AstraZeneca
Phase 2
124
Aachen, Essen, Frankfurt, Greifswald, Heidelberg, Kiel, Leipzig, Münster
2026-02-10
Recruiting
Technische Universität Dresden
Phase 2
220
Aachen, Augsburg, Berlin, Chemnitz, Cologne, Dresden, Frankfurt am Main, Greifswald
2026-01-21
Recruiting
Acupuncture Mechanism in Relief of Gag Reflex
NCT07664826Gag (Pharyngeal) Reflex
University Medicine Greifswald
Not applicable
30
Greifswald
2026-01-21
Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
NCT07224581GRIN-related Neurodevelopmental Disorder
DrugRadiprodil
GRIN Therapeutics, Inc.
Phase 3
100
Greifswald, Leipzig
2026-01-05
Recruiting
German Center for Neurodegenerative Diseases (DZNE)
Not applicable
554
Karlsruhe, Konstanz, Reutlingen, Darmstadt, Hanover, Göttingen, Greifswald, Rostock
2026-01-01
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Greifswald, Lübeck, Würzburg
2025-12-23
Recruiting
Autophagy-Enhancers to Reduce Sleep Disturbances
NCT07383311Mild Cognitive Impairment Due to Alzheimer's Disease, Subjective Cognitive Decline (SCD)
University Medicine Greifswald
Not applicable
76
Greifswald
2025-10-28
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Aachen, Bad Homburg, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Greifswald
2025-09-02
Active, closed
Merz Therapeutics GmbH
Phase 3
997
Berlin, Frankfurt, Greifswald, Kassel, Kiel
2025-08-21
Active, closed
Merz Therapeutics GmbH
Phase 3
808
Berlin, Frankfurt, Greifswald, Kassel, Kiel
2025-08-21
Recruiting
INNODIA Family & Friends Early-Stage T1D Detection Protocol
NCT07118098Type 1 Diabetes (T1D), Pre Diabetes
INNODIA iVZW
Observational
30,000
Greifswald
2025-06-25
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Marburg, Berlin, Bochum, Erbach im Odenwald, Essen, Greifswald, Heidelberg, Münster
2025-06-23
Recruiting
Technische Universität Dresden
Phase 2
76
Aachen, Chemnitz, Dresden, Erlangen, Essen, Frankfurt am Main, Greifswald, Halle
2025-06-17
Not yet open
Coronary and Cerebral Microvascular Dysfunction in Neurological Diseases
NCT07009990Stroke, Epilepsy, Transient Global Amnesia (TGA)
University Medicine Greifswald
Observational
100
Greifswald
2025-06
Recruiting
Prof. Dr. Dr. Birgit Burkhardt
Phase 1
18
Göttingen, Greifswald, Essen, Mainz, Berlin
2025-05-16
By invitation
Acceptance of Mandibular Advancement Devices
NCT06970171Obstructive Sleep Apnea Syndrome (OSAS)
University Medicine Greifswald
Not applicable
28
Greifswald
2025-05-05
Recruiting
Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.
NCT06809101Cancer, Cancer-related Problem/Condition, Chemotherapy, Chemotherapy-induced Neutropenia
Pomeranian Medical University Szczecin
Observational
265
Greifswald, Rostock
2025-03-17
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Aachen, Berlin, Cologne, Greifswald, Halle, Rostock, Zwickau
2025-02-27
Recruiting
Dianthus Therapeutics
Phase 3
256
München, Sande, Aachen, Greifswald, Rüdersdorf
2025-02-10
Active, closed
AbbVie
Phase 3
468
Erbach im Odenwald, Westerstede, Greifswald, Bielefeld, Ibbenbueren, Siegen, Chemnitz, Leipzig
2025-02-10
Recruiting
Colorectal Resections in Patients With Retroperitoneal Sarcoma
NCT06943612Sarcoma, Soft Tissue, Retroperitoneal Sarcoma
Heidelberg University
Observational
120
Mannheim, Göttingen, Berlin, Cologne, Dresden, Erlangen, Greifswald, Halle
2025-01-27
Recruiting
EUthyroid
Not applicable
4,500
Greifswald
2024-12-30
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Greifswald, Leipzig, München, Stuttgart
2024-12-16
Active, closed
AbbVie
Observational
1,314
Heidelberg, Tübingen, Hoppegarten, Bad Homburg, Oldenburg, Greifswald, Siegen, Velbert
2024-11-26
Recruiting
UCB Biopharma SRL
Phase 3
450
Berlin, Cologne, Dessau, Dresden, Freiburg im Breisgau, Greifswald, Herne, Jena
2024-11-21
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Regensburg, Dresden, Berlin, Giessen, Greifswald, Heidelberg, Homburg
2024-10-24
Active, closed
Ipsen
Phase 2
670
Berlin, Dresden, Essen, Frankfurt, Gera, Göppingen, Greifswald, Ulm
2024-10-10
Active, closed
Genmab
Phase 3
699
Bonn, Dortmund, Dresden, Greifswald, Hamburg, Hanover, Mannheim, München
2024-09-25
By invitation
AOP Orphan Pharmaceuticals AG
Observational
110
Berlin, Dresden, Greifswald
2024-07-31
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Aachen, Greifswald, Halle, Rostock
2024-06-28
Active, closed
Genmab
Phase 3
621
Berlin, Dresden, Essen, Giessen, Greifswald, Hanover, Leipzig, München
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Stuttgart, Greifswald, Bielefeld, Solingen
2024-05-24
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
Berlin, Cologne, Freiburg im Breisgau, Greifswald, Halle, Kiel, Münster, Stuttgart
2024-04-15
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Aachen, Berlin, Erlangen, Essen, Greifswald, Hanover, Mainz, München
2024-03-29
Recruiting
University Hospital Muenster
Observational
2,000
Chemnitz, Aachen, Greifswald, Leipzig, Münster, Tübingen
2024-03-01
Recruiting
AstraZeneca
Phase 3
1,145
Berlin, Erlangen, Essen, Freiburg im Breisgau, Greifswald, Hamburg, Hanover, Leipzig
2023-12-14
Recruiting
AOP Orphan Pharmaceuticals AG
Phase 4
110
Berlin, Dresden, Greifswald
2023-12-06
By invitation
University Medicine Greifswald
Not applicable
36
Greifswald
2023-11-03
Active, closed
Ipsen
Phase 3
759
Berlin, Greifswald, Haag in Oberbayern, Kassel, München
2023-10-12
Active, closed
Ipsen
Phase 3
751
Berlin, Greifswald, Hessen, München
2023-09-29
Recruiting
Universität des Saarlandes
Phase 3
330
Homburg, Aschaffenburg, Berlin, Dresden, Giessen, Greifswald, Halle, Karlsruhe
2023-06-07
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Cottbus, Dresden, Greifswald, Hamburg, Heidelberg, Marburg, Tübingen, Ulm
2023-03-29
Active, closed
AstraZeneca
Observational
551
Heidelberg, Erlangen, Bad Bramstedt, Schleswig-Holstein, Greifswald, Cologne, D Sseldorf, Herne
2023-02-27
Recruiting
University of Leipzig
Phase 4
258
Aachen, Augsburg, Berlin, Bonn, Frankfurt, Freiburg im Breisgau, Greifswald, Halle
2023-02-10
Active, closed
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
NCT05619653COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction
DrugsLosartan·Prednisolone
Valentina Puentmann
Phase 3
279
Frankfurt am Main, Greifswald, Kiel, Ulm
2022-12-12
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Erlangen, Trier, Würzburg, Cottbus, Potsdam, Frankfurt am Main, Hanover, Greifswald
2022-11-21
Active, closed
University Medicine Greifswald
Observational
110
Greifswald
2022-10-11
Recruiting
University of Leipzig
Phase 2
213
Berlin, Bonn, Cottbus, Erlangen, Greifswald, Hamburg, Kassel, Koblenz
2022-09-27
Recruiting
University Medicine Greifswald
Observational
60
Greifswald
2022-09-21
Active, closed
European Myeloma Network B.V.
Phase 3
117
Chemnitz, Düsseldorf, Greifswald, Hamburg
2022-04-19
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Aachen, Berlin, Dresden, Greifswald, Hamburg, Koblenz, Mainz
2022-04-11
Recruiting
University Medicine Greifswald
Not applicable
52
Greifswald
2021-11-02
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Bad Krozingen, Berlin, Cologne, Dresden, Düsseldorf, Freiburg im Breisgau, Greifswald, Hanover
2021-08-04
Active, closed
Incyte Corporation
Phase 3
654
Amberg, Berlin, Essen, Giessen, Greifswald, Landshut, Mainz, Mannheim
2021-04-15
Active, closed
Hoffmann-La Roche
Phase 3
769
Dresden, Greifswald, Hanover, Leipzig, Münster, Tübingen, Ulm, Wiesbaden
2020-12-03
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
NCT04065399Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia
DrugsCobicistat·Revumenib
Syndax Pharmaceuticals
Phase 1/2
447
Ulm, Essen, Greifswald, Gutenberg, Hamburg, Leipzig, Nuremberg
2019-11-05
Active, closed
Pazopanib Vs. Pazopanib Plus Gemcitabine
NCT02203760Leiomyosarcoma or Carcinosarcoma
DrugsPazopanib·Gemcitabine
North Eastern German Society of Gynaecological Oncology
Phase 2
58
Bonn, Berlin, Greifswald, Bad Saarow, Dresden, Essen, Jena, Tübingen
2019-10-16
Active, closed
RECORDATI GROUP
Observational
125
Berlin, Greifswald
2019-09-30
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Heidelberg, Greifswald, Mainz, Homburg, Leipzig, Donaueschingen, Dresden, Hamburg
2019-09-23
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Greifswald, Hanover
2019-09-12
Recruiting
Acupuncture for Pain Control After Ambulatory Knee Arthroscopy
NCT04134702Postoperative Pain; Knee Arthroscopy; Acupuncture
University Medicine Greifswald
Not applicable
60
Greifswald
2019-02-01
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Cologne, Giessen, Greifswald, Heidelberg, Würzburg
2018-12-01
Active, closed
Fondazione Michelangelo
Phase 3
650
Berlin, Bottrop, Coburg, Dortmund, Dresden, Frankfurt, Gera, Greifswald
2018-09-07
Active, closed
Hoffmann-La Roche
Phase 3
927
Dresden, Greifswald, Stuttgart, Ulm, Westerstede, Wiesbaden
2018-05-28
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Berlin, Dresden, Greifswald, Jena, Leer
2017-05-03
Active, closed
Eisai Inc.
Phase 3
1,069
Stuttgart, Tübingen, München, Frankfurt am Main, Hanover, Greifswald, Münster, Homburg/Saar
2016-10-13
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Berlin, Erlangen, Essen, Freiburg im Breisgau, Göttingen, Greifswald, Hamburg, Hanover
2015-04-22
Active, closed
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
NCT01934725Brain Infarction, Ischemic Stroke, Thrombosis, Foramen Ovale, Patent
SECRETO Study Consortium
Observational
1,200
Greifswald
2013-11
Rows per page Showing 1–79 of 79
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany/city/greifswald

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 79 of those studies with a site in Greifswald.

How many clinical trials are recruiting in Greifswald?

43 of the 79 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 28 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Greifswald), 79 studies
PhaseStudiesRecruitingShare
Phase 3321340.5%
Observational17821.5%
Not applicable11813.9%
Phase 211713.9%
Phase 1/2435.1%
Phase 4333.8%
Phase 1111.3%

Most active sponsors

Lead sponsors with the most studies (Greifswald)
Lead sponsorStudiesRecruiting
University Medicine Greifswald137
Hoffmann-La Roche52
AstraZeneca32
Ipsen30
Janssen Research & Development, LLC31
AbbVie20
AOP Orphan Pharmaceuticals AG21
European Myeloma Network B.V.21
Genmab20
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.